AstraZeneca (LSE:AZN) Forward PE Ratio

: 16.13 (As of Today)

View and export this data going back to 1993. Start your Free Trial

AstraZeneca's Forward PE Ratio for today is 16.13.

AstraZeneca's PE Ratio without NRI for today is 33.27.

AstraZeneca's PE Ratio for today is 35.39.

AstraZeneca Forward PE Ratio Historical Data

The historical data trend for AstraZeneca's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => 17.06 [1] => 12.63 [2] => 19.12 [3] => 19.72 [4] => 23.75 [5] => 20.20 [6] => 17.89 [7] => 17.67 [8] => 16.18 [9] => 16.42 )

AstraZeneca Annual Data

Trend

2015-12

2016-12

2017-12

2018-12

2019-12

2020-12

2021-12

2022-12

2023-12

2024-04

Forward PE Ratio

17.06

12.63

19.12

19.72

23.75

20.20

17.89

17.67

16.18

16.42

AstraZeneca Quarterly Data
	2015-12	2016-03	2016-06	2016-09	2016-12	2017-03	2017-06	2017-09	2017-12	2018-03	2018-06	2018-09	2018-12	2019-03	2019-06	2019-09	2019-12	2020-03	2020-06	2020-09	2020-12	2021-03	2021-06	2021-09	2021-12	2022-03	2022-06	2022-09	2022-12	2023-03	2023-06	2023-09	2023-12	2024-03
Forward PE Ratio	17.06	13.48	14.35	15.43	12.63	16.84	17.83	17.30	19.12	20.04	20.49	20.16	19.72	22.47	23.15	23.04	23.75	20.08	26.32	23.20	20.20	20.00	23.98	17.99	17.89	19.16	19.57	14.16	17.67	19.27	19.42	15.97	16.18	16.03

Competitive Comparison

For the Drug Manufacturers - General subindustry, AstraZeneca's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AstraZeneca Forward PE Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Forward PE Ratio falls into.

AstraZeneca Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

AstraZeneca (LSE:AZN) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

AstraZeneca Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca (LSE:AZN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (LSE:AZN) » Definitions » Forward PE Ratio

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:USA AZN:Sweden AZNN:Mexico AZNl:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.